Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

1.385 +0.005 (+0.36%)
Streaming Delayed Price Updated: 9:46 AM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript ↗
MGNX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
Earnings Scheduled For March 15, 2023 ↗
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
The Latest Analyst Ratings for Macrogenics ↗
 
Via Benzinga
7 Analysts Have This to Say About Macrogenics ↗
 
Via Benzinga
Expert Ratings for Macrogenics ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Macrogenics ↗
 
Via Benzinga
News headline image
Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Shares of MacroGenics Jumped Thursday ↗
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Where Macrogenics Stands With Analysts ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients ↗
 
Via Benzinga
News headline image
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday ↗
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga
News headline image
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56% ↗
Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday. 
Via Benzinga
News headline image
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box ↗
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
News headline image
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch ↗
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching. 
Via Investor's Business Daily
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.